Results for tag: "Lumbar Degenerative Disc Disease"

Lumbar degenerative disc disease (DDD) refers to the gradual deterioration of the intervertebral discs in the lumbar spine. These spinal discs, composed of a soft inner core (nucleus pulposus) and a tough outer ring (annulus fibrosus), act as shock absorbers for the spine, allowing for flexibility and movement. Over time, discs may lose hydration and elasticity, leading to reduced disc height and potential bulging or herniation. The process can result in chronic lower back pain, instability, and nerve-related symptoms if the degenerative changes compress nearby spinal nerves. Factors such as age, genetics, mechanical loading, and lifestyle choices can influence the progression of DDD. Treatment for lumbar DDD ranges from conservative non-surgical approaches such as physical therapy and medication to interventional procedures like spinal injections and surgeries, including discectomy, laminectomy, and spinal fusion. In the market for treatments of lumbar DDD, various companies have emerged, focusing on both innovative surgical solutions and non-operative care products. Prominent players include companies such as Medtronic, which offers advanced spinal care technologies, DePuy Synthes from Johnson & Johnson providing spinal devices and instruments, Zimmer Biomet with a portfolio including fusion and motion preservation devices, Stryker featuring spinal implants and interventional spine products, and NuVasive, known for minimally invasive surgical solutions and spinal hardware. These companies are at the forefront of developing and marketing treatments and devices intended Show Less Read more